Clinical Trial - Trial HKUCTR-2799
Access comprehensive clinical trial information for HKUCTR-2799 through Pure Global AI's free database. This Phase 2 trial is sponsored by Dr. Chi-leung Chiang and is currently Recruiting. The study focuses on Neoplasm.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to HKU CLINICAL TRIALS REGISTRY data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
HKUCTR-2799
Phase 2
Recruiting
drug
Trial Details
HKU CLINICAL TRIALS REGISTRY • HKUCTR-2799
Untitled Trial
Phase II prospective study of bintrafusp alfa in previously treated patients with recurrent and metastatic (R/M) non-keratinizing nasopharyngeal carcinoma (NPC)
Study Focus
Sponsor & Location
Dr. Chi-leung Chiang
Merck Healthcare KGaA, Darmstadt, Germany
China
Timeline & Enrollment
Phase 2
N/A
Jan 30, 2023
ICD-10 Classifications
Neoplasms
Benign neoplasms
In situ neoplasms
Personal history of other neoplasms
Benign neoplasm: Other specified sites
Data Source
HKU CLINICAL TRIALS REGISTRY
HKUCTR-2799
Non-Device Trial